Prot #104-201509: A 6-MONTH, MULTICENTER, PHASE 3, OPEN-LABEL EXTENSION SAFETY STUDY OF OTO-104 GIVEN AT 3-MONTH INTERVALS BY INTRATYMPANIC INJECTION IN SUBJECTS WITH UNILATERAL MENIERE’S DISEASE

Project: Research project

Project Details

StatusFinished
Effective start/end date12/1/16 → 12/1/19

Funding

  • INC Research, LLC (Prot #104-201509 // Prot #104-201509)
  • Otonomy, Inc. (Prot #104-201509 // Prot #104-201509)